BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Healthcare company Fresenius SE (FSNUF.PK, FSNPF.PK) said Sunday that its Supervisory Board appointed Stephan Sturm (52) as Chief Executive Officer as of July 1, 2016. Stephan Sturm succeeds Ulf Mark Schneider (50), who has decided to leave the company effective June 30, 2016 to pursue another opportunity.
Fresenius confirmed its guidance for 2016. Sales are expected to increase by 6% to 8% in constant currency. Net income attributable to shareholders is expected to grow by 8% to 12% in constant currency.
The company also confirmed its mid-term outlook. For 2019, Group sales are expected to reach 36 billion euros to 40 billion euros, at comparable exchange rates; including small and mid-size acquisitions. Group net income attributable to shareholders is expected to increase to 2.0 billion euros to 2.25 billion euros.
Copyright RTT News/dpa-AFX